877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Hydroxyarenes, Tricyclic antidepressants

Categories

Antidepressants (1)
Aromatic compounds (1)
Chloroarenes (1)
Cyclic compounds (1)
Drugs acting on the nervous system (1)
Piperazines (1)
Psychoactive drugs (1)
Psychopharmacology (1)
Six-membered rings (1)

7-Hydroxyamoxapine (37081-76-8)  
7-Hydroxyamoxapine is an active metabolite of amoxapine (Asendin). It contributes to amoxapine's pharmacology.

Related Results:
viloxazine (46817-91-8)  
Vivalan  ·  Viloxazine Hydrochloride  ·  Emovit
Viloxazine (trade names Vivalan, Emovit, Vivarint and Vicilan) is a morpholine derivative and is a selective norepinephrine reuptake inhibitor (NRI). It was used as an antidepressant in some European countries, and produced a stimulant effect that is similar to the amphetamines, except without any signs of dependence. It was discovered and brought to market in 1976 by Imperial Chemical Industries and was withdrawn from the market in the early 2000s for business reasons.
Milnacipran (92623-85-3, 96847-55-1)  
Milnacipran (trade names Ixel, Savella, Dalcipran, Toledomin) is a serotonin–norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatment of major depressive disorder in the USA, but it is in other countries.
Imipraminoxide (6829-98-7)  
imipramine-N-oxide  ·  5-(3-(dimethylamino)propyl)-10,11-dihydro-5H- dibenz(b,f)azepine 5-(3-N-oxide)  ·  imipramine N-oxide hydrochloride
Nortriptyline hydrochloride (894-71-3)  
Nortriptyline  ·  Pamelor  ·  Aventyl
Nortriptyline, sold under the brand names Allegron, Aventyl, Noritren, Nortrilen, and Pamelor among others, is a tricyclic antidepressant (TCA) used to treat clinical depression. Another licensed use for it is in the treatment of childhood bedwetting. Off-label uses include chronic pain and migraine and labile affect in some neurological disorders.
mianserin (78684-63-6, 24219-97-4)  
Mianserin Hydrochloride  ·  Org GB 94  ·  Tolvon
Mianserin, sold under the brand name Tolvon among others, is an atypical antidepressant which is used in the treatment of depression in Europe and elsewhere in the world. It is a tetracyclic antidepressant (TeCA). Mianserin is closely related to mirtazapine, both chemically and in terms of its actions and effects, although there are significant differences between the two drugs.
Agomelatine (138112-76-2)  
Agomelatine (brand names Valdoxan, Melitor, Thymanax) is an atypical antidepressant developed by the pharmaceutical company Servier. It is marketed for the treatment of major depressive disorder, primarily for its relatively favorable side effect profile: it avoids the weight gain, sexual dysfunction, and severe withdrawal associated with the most commonly used classes of antidepressants (SSRIs, SNRIs, tricyclics), while providing similar therapeutic benefit. Due to its distinctive mechanism of action, agomelatine is also studied for its effects on sleep regulation.
doxepin (1668-19-5)  
Sinequan  ·  Mareen  ·  Doxepin Hydrochloride
Doxepin Hydrochloride (1229-29-4, 4698-39-9)  
Doxepin  ·  Sinequan  ·  Mareen
moclobemide (71320-77-9)  
Arima  ·  Manerix  ·  Aurorix
Moclobemide (sold as Amira, Aurorix, Clobemix , Depnil and Manerix) is a reversible inhibitor of monoamine oxidase A (RIMA) drug primarily used to treat depression and social anxiety. It is not approved for use in the United States, but is approved in other Western countries such as the UK and Australia (TGA approved in December 2000). It is produced by affiliates of the Hoffmann–La Roche pharmaceutical company.
Cidoxepin hydrochloride (1229-29-4, 25127-31-5)  
Doxepin  ·  Sinequan  ·  Mareen
Zimelidine dihydrochloride (60525-15-7)  
Zimelidine  ·  Zimeldine  ·  H-102-09
Brofaromine (63638-91-5)  
Brofaromine (proposed brand name Consonar) is a reversible inhibitor of monoamine oxidase A (RIMA) discovered by Ciba-Geigy. The compound was primarily researched in the treatment of depression and anxiety but its development was dropped before it was brought to market. Brofaromine also acts as a serotonin reuptake inhibitor, and its dual pharmacologic effects offered promise in the treatment of a wide spectrum of depressed patients while producing less severe anticholinergic side effects in comparison with older standard drugs like the tricyclic antidepressants.
Dothiepin hydrochloride (897-15-4)  
Dothiepin  ·  Prothiaden  ·  Dosulepin
Dothiepin (113-53-1, 25627-38-7)  
Prothiaden  ·  Dothiepin Hydrochloride  ·  Dosulepin
Dosulepin, also known as dothiepin and sold under the brand name Prothiaden among others, is a tricyclic antidepressant (TCA) which is used in the treatment of depression. Dosulepin was once the most frequently prescribed antidepressant in the United Kingdom, but it is no longer widely used due to its relatively high toxicity in overdose without therapeutic advantages over other TCAs. It acts as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also has other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects.
Dosulepine (113-53-1, 897-15-4)  
Dothiepin  ·  Prothiaden  ·  Dothiepin Hydrochloride
Protriptyline hydrochloride (1225-55-4)  
Protriptyline  ·  Vivactil
Protriptyline, sold under the brand name Vivactil among others, is a tricyclic antidepressant (TCA), specifically a secondary amine, indicated for the treatment of depression and attention-deficit hyperactivity disorder (ADHD). Uniquely among most of the TCAs, protriptyline tends to be energizing instead of sedating, and is sometimes used for narcolepsy to achieve a wakefulness-promoting effect. TCAs including protriptyline are also used to reduce the incidence of recurring headaches such as migraine, and for other types of chronic pain.
Reboxetine (98769-81-4, 98819-76-2, 71620-89-8)  
Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. It is the (S,S)-(+)-enantiomer of reboxetine and is even more selective in comparison. However, recently it has been shown that esreboxetine could be effective in fibromyalgia patients.
Related searches
Hydroxyarenes
Tricyclic antidepressants
Next Page >